These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33684065)

  • 1. Clinical Manifestations and Outcomes in Disease-Modifying Antirheumatic Drug-Naive Adult Patients with Chronic Chikungunya Arthritis.
    Medina-Cintrón N; Martínez I; Pérez-Ríos N; Berríos-López Y; Vilá LM
    Am J Trop Med Hyg; 2021 Mar; 104(5):1741-1746. PubMed ID: 33684065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent chikungunya arthritis: a 24-week randomized controlled open label study.
    Ravindran V; Alias G
    Clin Rheumatol; 2017 Jun; 36(6):1335-1340. PubMed ID: 27699657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chikungunya arthritis - should we expect it to become more common in Portuguese rheumatology?
    Almeida DE; Costa E; Pinto AS; Silva JL; Neves JS; Ribeiro AR; Cerqueira M
    Acta Reumatol Port; 2020; 45(4):298-300. PubMed ID: 33420775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Clinical Features, Pathogenesis and Methotrexate Therapy of Chronic Chikungunya Arthritis.
    Amaral JK; Taylor PC; Teixeira MM; Morrison TET; Schoen RT
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30909365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatic Manifestations in Patients with Chikungunya Infection.
    Arroyo-Ávila M; Vilá LM
    P R Health Sci J; 2015 Jun; 34(2):71-7. PubMed ID: 26061056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Manifestations Associated with Peripheral Joint Involvement in Patients with Acute Chikungunya Virus Infection.
    Arroyo-Ávila M; Cabán A; García-Rivera EJ; Irizarry-Pérez M; Torres H; Gorbea H; Vilá LM
    Am J Trop Med Hyg; 2017 Apr; 96(4):916-921. PubMed ID: 28138049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Chikungunya virus infection in patients with established rheumatoid arthritis.
    Bautista-Vargas M; Puerta-Sarmiento G; Cañas CA
    Clin Rheumatol; 2020 Dec; 39(12):3639-3642. PubMed ID: 32514679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheumatic manifestations of Chikungunya virus infection: Prevalence, patterns, and enthesitis.
    Benjamanukul S; Osiri M; Chansaenroj J; Chirathaworn C; Poovorawan Y
    PLoS One; 2021; 16(4):e0249867. PubMed ID: 33886579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chikungunya virus: a rheumatologist's perspective.
    Runowska M; Majewski D; Niklas K; Puszczewicz M
    Clin Exp Rheumatol; 2018; 36(3):494-501. PubMed ID: 29533749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory biomarkers, disease activity index, and self-reported disability may be predictors of chronic arthritis after chikungunya infection: brief report.
    Sepúlveda-Delgado J; Vera-Lastra OL; Trujillo-Murillo K; Canseco-Ávila LM; Sánchez-González RA; Gómez-Cruz O; Lugo-Trampe A; Fernández-Salas I; Danis-Lozano R; Contreras-Contreras A; Mendoza-Torres A; Domínguez-Arrevillaga S; Mena-Vela BA; Ocaña-Sibilla M; Ramirez-Valdespino JC; Jara LJ
    Clin Rheumatol; 2017 Mar; 36(3):695-699. PubMed ID: 27680539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chikungunya Virus-Associated Disease.
    Hua C; Combe B
    Curr Rheumatol Rep; 2017 Oct; 19(11):69. PubMed ID: 28983760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chikungunya virus infection in Aruba: Diagnosis, clinical features and predictors of post-chikungunya chronic polyarthralgia.
    Huits R; De Kort J; Van Den Berg R; Chong L; Tsoumanis A; Eggermont K; Bartholomeeusen K; Ariën KK; Jacobs J; Van Esbroeck M; Bottieau E; Cnops L
    PLoS One; 2018; 13(4):e0196630. PubMed ID: 29709007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions for treating patients with chikungunya virus infection-related rheumatic and musculoskeletal disorders: A systematic review.
    Martí-Carvajal A; Ramon-Pardo P; Javelle E; Simon F; Aldighieri S; Horvath H; Rodriguez-Abreu J; Reveiz L
    PLoS One; 2017; 12(6):e0179028. PubMed ID: 28609439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tender and swollen joint counts are poorly associated with disability in chikungunya arthritis compared to rheumatoid arthritis.
    Watson H; Nogueira-Hayd RL; Rodrigues-Moreno M; Naveca F; Calusi G; Suchowiecki K; Firestein GS; Simon G; Chang AY
    Sci Rep; 2021 Sep; 11(1):18578. PubMed ID: 34535727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Characteristics, Histopathology, and Tissue Immunolocalization of Chikungunya Virus Antigen in Fatal Cases.
    Sharp TM; Keating MK; Shieh WJ; Bhatnagar J; Bollweg BC; Levine R; Blau DM; Torres JV; Rivera A; Perez-Padilla J; Munoz-Jordan J; Sanabria D; Fischer M; Rivera Garcia B; Tomashek KM; Zaki SR
    Clin Infect Dis; 2021 Jul; 73(2):e345-e354. PubMed ID: 32615591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of clinical presentation and out-comes of Chikungunya and Dengue virus infections in patients with acute undifferentiated febrile illness from the Sindh region of Pakistan.
    Shahid U; Farooqi JQ; Barr KL; Mahmood SF; Jamil B; Imitaz K; Azizullah Z; Malik FR; Prakoso D; Long MT; Khan E
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008086. PubMed ID: 32203509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Andrographolide - A prospective remedy for chikungunya fever and viral arthritis.
    Gupta S; Mishra KP; Gupta R; Singh SB
    Int Immunopharmacol; 2021 Oct; 99():108045. PubMed ID: 34435582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Persistence of Chikungunya Virus-Associated Manifestations and Anti-Chikungunya Virus Antibody in Southern Thailand: 5 Years After an Outbreak in 2008-2009.
    Ninla-Aesong P; Mitarnun W; Noipha K
    Viral Immunol; 2020 Mar; 33(2):86-93. PubMed ID: 31976828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between Patient Global Assessment scores and pain, physical function, and fatigue in rheumatoid arthritis: a post hoc analysis of data from phase 3 trials of tofacitinib.
    Strand V; Kaine J; Alten R; Wallenstein G; Diehl A; Shi H; Germino R; Murray CW
    Arthritis Res Ther; 2020 Oct; 22(1):243. PubMed ID: 33059710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Disease Activity Score in 28 joints with ESR (DAS28), Clinical Disease Activity Index (CDAI), Health Assessment Questionnaire Disability Index (HAQ-DI) & Routine Assessment of Patient Index Data with 3 measures (RAPID3) for assessing disease activity in patients with rheumatoid arthritis at initial presentation.
    Kumar BS; Suneetha P; Mohan A; Kumar DP; Sarma KVS
    Indian J Med Res; 2017 Nov; 146(Supplement):S57-S62. PubMed ID: 29578196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.